Next Article in Journal
Drug Development for Pediatric Populations: Regulatory Aspects
Next Article in Special Issue
The Influence of Milling on the Dissolution Performance of Simvastatin
Previous Article in Journal
Enhanced Dissolution and Oral Bioavailability of Piroxicam Formulations: Modulating Effect of Phospholipids
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2010, 2(4), 351-363;

Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development

Biopharmaceutical department, Faculty of Pharmacy, University of Auvergne 28 Place H. Dunant, BP 38, 63001 Clermont-Ferrand, France
Galenical & Analytical Development, Pharmaceutical Division, F. Hoffmann-La Roche Ltd., CH-4070, Basel, Switzerland
Author to whom correspondence should be addressed.
Received: 12 October 2010 / Revised: 26 October 2010 / Accepted: 28 October 2010 / Published: 1 November 2010
(This article belongs to the Special Issue Recent Developments and Future Perspectives in Dissolution Testing)
Full-Text   |   PDF [184 KB, uploaded 1 November 2010]   |  


Standard compendia dissolution apparatus are the first choice for development of new dissolution methods. Nevertheless, limitations coming from the amount of material available, analytical sensitivity, lack of discrimination or biorelevance may warrant the use of non compendial methods. In this regard, the use of small volume dissolution methods offers strong advantages. The present study aims primarily to evaluate the dissolution performance of various drug products having different release mechanisms, using commercially available small volume USP2 dissolution equipment. The present series of tests indicate that the small volume dissolution is a useful tool for the characterization of immediate release drug product. Depending on the release mechanism, different speed factors are proposed to mimic common one liter vessel performance. In addition, by increasing the discriminating power of the dissolution method, it potentially improves know how about formulations and on typical events which are evaluated during pharmaceutical development such as ageing or scale–up. In this regard, small volume dissolution is a method of choice in case of screening for critical quality attributes of rapidly dissolving tablets, where it is often difficult to detect differences using standard working conditions. View Full-Text
Keywords: Dissolution; Small volume; Discrimination; Screening; Quality By Design Dissolution; Small volume; Discrimination; Screening; Quality By Design

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Scheubel, E.; Lindenberg, M.; Beyssac, E.; Cardot, J.-M. Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development. Pharmaceutics 2010, 2, 351-363.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top